Tenet Healthcare Corporation (THC) Is a Trending Stock: Facts to Know Before Betting on It

Tenet (THC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks Investment Research • Feb 19, 2026

Tenet Healthcare Beats Q4 Earnings: But 2026 EBITDA Margin May Decline

THC tops Q4 estimates with strong EBITDA growth, but 2026 guidance midpoint hints at a potential margin dip despite a higher revenue outlook.

Zacks Investment Research • Feb 12, 2026

Tenet Healthcare Quarterly Profit Surges As Hospital, Surgery Demand Grows

Tenet Healthcare Corporation (NYSE: THC) reported fourth-quarter sales of $5.527 billion, up around 8.9% year over year.

Benzinga • Feb 11, 2026

Tenet Healthcare Corporation (THC) Q4 2025 Earnings Call Transcript

Tenet Healthcare Corporation (THC) Q4 2025 Earnings Call Transcript

Seeking Alpha • Feb 11, 2026

Tenet Healthcare Remains Compelling Even After A 17.3% Post-Earnings Surge

Tenet Healthcare Corporation delivered a strong Q4 2025, beating revenue and EPS estimates, and provided favorable 2026 guidance. THC's Ambulatory Care segment drove growth, with a 13.8% revenue increase and robust EBITDA, despite a slight margin decline. The announced $1.9B transaction with CommonSpirit introduces uncertainty but will reduce net debt and grant full ownership of Conifer.

Seeking Alpha • Feb 12, 2026

Tenet Reports Strong Fourth Quarter and FY 2025 Results; Provides 2026 Financial Outlook

DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended December 31, 2025. "2025 extended Tenet's track record of strong revenue growth, disciplined operations, improved margins and robust free cash flow generation," said Saum Sutaria, M.D., Chairman and Chief Executive Officer of Tenet. "We see continued demand for acute care and ambulatory surgical services in our markets and are confident in our ability to execute on our str.

Business Wire • Feb 11, 2026

Tenet Healthcare (THC) Q4 Earnings and Revenues Surpass Estimates

Tenet Healthcare (THC) came out with quarterly earnings of $4.7 per share, beating the Zacks Consensus Estimate of $4.08 per share. This compares to earnings of $3.44 per share a year ago.

Zacks Investment Research • Feb 11, 2026

Compared to Estimates, Tenet (THC) Q4 Earnings: A Look at Key Metrics

The headline numbers for Tenet (THC) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks Investment Research • Feb 11, 2026

Will Lower Patient Days Affect Tenet Healthcare's Q4 Earnings?

THC heads into Q4 earnings with solid expected revenue and admissions growth, but a sharp drop in hospital patient days could cloud the bottom-line outlook.

Zacks Investment Research • Feb 10, 2026

Profit Therapy: 3 Medical Stocks Ready to Deliver Q4 Beat

THC, UHS and OPCH look poised to beat Q4 estimates as volumes, admissions and revenue trends improve.

Zacks Investment Research • Feb 6, 2026